bemcentinib,pembrolizumab
bergenbio,merck
['pembro', 'bemcentinib']
join the presentation session by matthew krebs ( ), alastair greystoke ( , ) &amp; anne thomas (leicester ecmc) on a phase iia trial evaluating the efficacy of axl/pd-1 inhibition with bemcentinib/pembrolizumab 
Experimental Cancer Medicine Centres develop new cancer therapies. Jointly funded @CR_UK @LPTrustUK @NIHRresearch @CSO_Scotland @ResearchWales @BelfastTrust